Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome

Documenti analoghi

• Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Nontransplant-Associated Chemotherapy: Final Results From a Post Hoc Analysis of Data From an Expanded-Access Program
  di: Kernan, Nancy A., et al.
  Pubblicazione: (2018)
• Pooled analysis of Day 100 survival for defibrotide‐treated patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation
  di: Richardson, Paul G., et al.
  Pubblicazione: (2020)
• Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation
  di: Richardson, Paul G., et al.
  Pubblicazione: (2017)
• A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting
  di: Tappe, William, et al.
  Pubblicazione: (2020)
• Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure
  di: Richardson, Paul G, et al.
  Pubblicazione: (2017)